- Home
- QNRX vs MTNB Comparison
QNRX vs MTNB Comparison
Compare QNRX & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- MTNB
- Stock Information
- Founded
- QNRX 2018
- MTNB 2013
- Country
- QNRX United States
- MTNB United States
- Employees
- QNRX N/A
- MTNB N/A
- Industry
- QNRX Medical/Dental Instruments
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- QNRX Health Care
- MTNB Health Care
- Exchange
- QNRX Nasdaq
- MTNB Nasdaq
- Market Cap
- QNRX 5.3M
- MTNB 2.6M
- IPO Year
- QNRX N/A
- MTNB N/A
- Fundamental
- Price
- QNRX $0.70
- MTNB $0.64
- Analyst Decision
- QNRX Strong Buy
- MTNB Hold
- Analyst Count
- QNRX 1
- MTNB 1
- Target Price
- QNRX $4.00
- MTNB N/A
- AVG Volume (30 Days)
- QNRX 1.4M
- MTNB 104.9K
- Earning Date
- QNRX 11-07-2024
- MTNB 11-13-2024
- Dividend Yield
- QNRX N/A
- MTNB N/A
- EPS Growth
- QNRX N/A
- MTNB N/A
- EPS
- QNRX N/A
- MTNB N/A
- Revenue
- QNRX N/A
- MTNB N/A
- Revenue This Year
- QNRX N/A
- MTNB N/A
- Revenue Next Year
- QNRX N/A
- MTNB N/A
- P/E Ratio
- QNRX N/A
- MTNB N/A
- Revenue Growth
- QNRX N/A
- MTNB N/A
- 52 Week Low
- QNRX $0.43
- MTNB $0.48
- 52 Week High
- QNRX $6.18
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- QNRX 54.60
- MTNB 45.43
- Support Level
- QNRX $0.47
- MTNB $0.48
- Resistance Level
- QNRX $0.75
- MTNB $0.60
- Average True Range (ATR)
- QNRX 0.10
- MTNB 0.06
- MACD
- QNRX 0.01
- MTNB 0.05
- Stochastic Oscillator
- QNRX 71.51
- MTNB 77.72
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.